Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period

[1]  A. Sette,et al.  Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status , 2022, Cell Host & Microbe.

[2]  J. Blankson,et al.  CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses , 2022, The Journal of clinical investigation.

[3]  Graham W. Taylor,et al.  Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts , 2022, Nature communications.

[4]  S. Mallal,et al.  SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron , 2022, Cell.

[5]  L. Kaderali,et al.  Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses , 2021, Cell Reports.

[6]  Maureen A. McGargill,et al.  Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response , 2021, Cell Host & Microbe.

[7]  Zheng Wang,et al.  The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study , 2021, The Lancet Microbe.

[8]  A. Sette,et al.  Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells , 2021, Science.

[9]  Sandeep Kumar Dhanda,et al.  Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames , 2021, Journal of virology.

[10]  A. Garcia-Basteiro,et al.  Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses , 2021, Nature Communications.

[11]  Naomi R. Waterlow,et al.  How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology , 2021, Proceedings of the National Academy of Sciences.

[12]  D. Jarrossay,et al.  Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 , 2021, Science.

[13]  A. Mehta,et al.  Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells , 2021, medRxiv.

[14]  Shibin Zhou,et al.  Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses. , 2021, The Journal of clinical investigation.

[15]  R. Thwaites,et al.  Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses , 2021, Trends in Microbiology.

[16]  K. Schnatbaum,et al.  Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination , 2021, Science.

[17]  A. Sette,et al.  Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers , 2021, The Journal of infectious diseases.

[18]  S. Kent,et al.  Systems serology detects functionally distinct coronavirus antibody features in children and elderly , 2021, Nature Communications.

[19]  A. Monto,et al.  Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses , 2021, The Journal of Infectious Diseases.

[20]  A. Sette,et al.  Adaptive immunity to SARS-CoV-2 and COVID-19 , 2021, Cell.

[21]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.

[22]  A. Wheatley,et al.  Adaptive immunity to human coronaviruses is widespread but low in magnitude , 2021, medRxiv.

[23]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.

[24]  B. Bosch,et al.  Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 , 2020, Scientific Reports.

[25]  P. Rosenstiel,et al.  Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 , 2020, Immunity.

[26]  Y. Choe,et al.  Global Seasonality of Human Coronaviruses: A Systematic Review , 2020, Open forum infectious diseases.

[27]  N. Miller,et al.  Recent endemic coronavirus infection is associated with less severe COVID-19. , 2020, The Journal of clinical investigation.

[28]  H. Goossens,et al.  Seasonal coronavirus protective immunity is short-lasting , 2020, Nature Medicine.

[29]  S. Perlman,et al.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis , 2020, Methods in molecular biology.

[30]  S. Mallal,et al.  Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.

[31]  S. Mallal,et al.  Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination , 2020, Journal of Virology.

[32]  H. Nair,et al.  Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2? , 2020, The Journal of infectious diseases.

[33]  Aaron M. Rosenfeld,et al.  Comprehensive mapping of immune perturbations associated with severe COVID-19 , 2020, Science Immunology.

[34]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.

[35]  Morten Nielsen,et al.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.

[36]  Gheyath K Nasrallah,et al.  Distinct antibody repertoires against endemic human coronaviruses in children and adults , 2020, bioRxiv.

[37]  A. Sette,et al.  The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients , 2020, Science Immunology.

[38]  Seasonality of Coronavirus 229E, HKU1, NL63, and OC43 From 2014 to 2020 , 2020, Mayo Clinic Proceedings.

[39]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[40]  J. Shaman,et al.  Direct Observation of Repeated Infections With Endemic Coronaviruses , 2020, medRxiv.

[41]  P. Murcia,et al.  Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019 , 2020, The Journal of Infectious Diseases.

[42]  Sandeep Kumar Dhanda,et al.  Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy , 2020, Journal of immunology research.

[43]  Yonatan H. Grad,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[44]  R. Scheuermann,et al.  A survey of known immune epitopes in the enteroviruses strains associated with acute flaccid myelitis. , 2019, Human immunology.

[45]  Morten Nielsen,et al.  IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..

[46]  R. Rabadán,et al.  Longitudinal active sampling for respiratory viral infections across age groups , 2019, Influenza and other respiratory viruses.

[47]  Zhènglì Shí,et al.  Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.

[48]  B. Pulendran,et al.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters , 2018, The Journal of clinical investigation.

[49]  Marie E Killerby,et al.  Human coronavirus circulation in the United States 2014–2017 , 2018, Journal of Clinical Virology.

[50]  S. Mallal,et al.  Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses , 2017, PloS one.

[51]  M. Mori,et al.  Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  E. Walsh,et al.  Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations , 2013, The Journal of infectious diseases.

[53]  K. Holmes,et al.  Detection of four human coronaviruses in respiratory infections in children: A one‐year study in Colorado , 2009, Journal of medical virology.

[54]  Samson S. Y. Wong,et al.  Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia , 2005, Journal of Virology.

[55]  B. Berkhout,et al.  Identification of a new human coronavirus , 2004, Nature Medicine.

[56]  E. Schouten,et al.  A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection , 2003, Journal of Clinical Epidemiology.

[57]  A. Cariou,et al.  Coronavirus 229E-Related Pneumonia in Immunocompromised Patients , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  F. Ennis,et al.  Human cytotoxic T-cell memory: long-lived responses to vaccinia virus , 1996, Journal of virology.

[59]  D. Tyrrell,et al.  The time course of the immune response to experimental coronavirus infection of man , 1990, Epidemiology and Infection.

[60]  D. Tyrrell,et al.  Respiratory Viruses , 2008 .